Current and emerging strategies to curb antibiotic-resistant urinary tract infections. Journal Abstract

Current and emerging strategies to curb antibiotic-resistant urinary tract infections.

Publication Date: 2024 May 07

Full Text Sources

Authors

Aaron Simoni; Laura Schwartz; Guillermo Yepes Junquera; Christina B Ching; John David Spencer

Abstract

OBJECTIVE

Rising rates of antibiotic resistance in uropathogenic bacteria compromise patient outcomes and prolong hospital stays. Consequently, new strategies are needed to prevent and control the spread of antibiotic resistance in uropathogenic bacteria. Over the past two decades, sizeable clinical efforts and research advances have changed urinary tract infection (UTI) treatment and prevention strategies to conserve antibiotic use. The emergence of antimicrobial stewardship, policies from national societies, and the development of new antimicrobials have shaped modern UTI practices. Future UTI management practices could be driven by the evolution of antimicrobial stewardship, improved and readily available diagnostics, and an improved understanding of how the microbiome affects UTI. Forthcoming UTI treatment and prevention strategies could employ novel bactericidal compounds, combinations of new and classic antimicrobials that enhance bacterial killing, medications that prevent bacterial attachment to uroepithelial cells, repurposing drugs, and vaccines to curtail the rising rates of antibiotic resistance in uropathogenic bacteria and improve outcomes in people with UTI.

Source

Nature reviews. Urology

Pub Types(s)

Journal Article

Language

English

PubMed ID

38714857